T CELL NOUVEAU
T Cell Nouveau is a clinical-stage biopharmaceutical company that focuses on curing solid tumors with hybrid CAR-T cell therapy.
T CELL NOUVEAU
Industry:
Biopharma Biotechnology Clinical Trials Medical
Founded:
2021-01-15
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.tcellnouveau.com
Status:
Active
Contact:
+81-3-6555-3304
Email Addresses:
[email protected]
Technology used in webpage:
HSTS Google Google Cloud Wix Google Cloud CDN
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.
resTORbio
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Official Site Inspections
http://www.tcellnouveau.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "T Cell Nouveau"
ティーセルヌーヴォー株式会社 | T Cell Nouveau Inc.
ティーセルヌーヴォー株式会社は臨床段階のバイオ医薬品企業であり、三重大学 珠玖研究室が開発した最先端のHybrid CAR-T細胞療法を用いて、免疫系を賦活化することにより固形がんを治療することを目指しています。T-cell NouveauSee details»
T Cell Nouveau Inc.
Jun 24, 2024 γδT Cell Project Adopted as Research and Development Support Program for Growth-Type Small and Medium Sized Enterprises (GO-TECH)See details»
T Cell Nouveau - Crunchbase Company Profile & Funding
Organization. T Cell Nouveau . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; Phone …See details»
Car-t細胞療法 | T Cell Nouveau、ティーセルヌーヴォー株式会社
ティーセルヌーヴォー株式会社は臨床段階のバイオメディカル企業であり、三重大学 珠玖研究室が開発した最先端のTCR like CAR-T細胞療法を用いて、免疫系を賦活化することにより固形 …See details»
T-Cell Nouveau 2025 Company Profile: Valuation, Funding
Jan 1, 2024 T-Cell Nouveau General Information Description. Operator of a biopharmaceutical company intended to treat solid tumors that do not respond to TCR-T cell therapy. The …See details»
T Cell Nouveau Overview | SignalHire Company Profile
Organization Website: tcellnouveau.com : T Cell Nouveau industries Biotech: Headquarters LocationSee details»
T Cell Nouveau | LinkedIn
T Cell Nouveau | LinkedInのフォロワー数93人。Clinical stage biopharmaceutical company with novel TCR like CAR-T cell therapy for solid tumors at affordable price | We are a clinical stage biopharmaceutical company aspiring to cure …See details»
T Cell Nouveau, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore T Cell Nouveau, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
T Cell Nouveau Inc. - VentureRadar
Website: https://www.tcellnouveau.com/ T Cell Nouveau Inc. specializes in pioneering CAR T-cell therapies with a focus on targeting GD2 antigen to combat cancer.See details»
T Cell Nouveau - Company Profile - Tracxn
Jan 27, 2025 T Cell Nouveau - Developer of CAR-T cell therapies for the treatment of cancer. Raised funding from 1 investor. Founded by Kazuto Takesako in the year 2021. T Cell …See details»
ティーセルヌーヴォー - STARTUP DB｜スタートアップ ...
社名 ティーセルヌーヴォー 設立日 2021.01.15 (5年目) 大学発 三重大学 住所 〒103-0012 東京都中央区日本橋堀留町1丁目9番10号日本橋ライフサイエンスビルディング7・6階C－16See details»
T Cell Nouveau Inc. moved HQ to Central Tokyo.
T Cell Nouveau Inc. headquarter moved to Tokyo-to, Chuo-ku, Kyobashi 1-6-13-204.See details»
ティーセルヌーヴォー株式会社 | InfoBase
三重大学珠玖研究室が開発した「Hybrid CAR-T細胞療法」の研究・開発を行っています。「Hybrid CAR-T細胞療法」は、T細胞の活性を高めるCARの特徴と、がん特異的なキラーT細胞 …See details»
T Cell Nouveau - Products, Competitors, Financials, Employees ...
Jun 1, 2013 tcellnouveau.com. Overview & Products; Financials; Founded Year 2021. Stage Seed VC | Alive. About T Cell Nouveau. T Cell Nouveau is a clinical-stage biopharmaceutical …See details»
T Cell Nouveau | Chuo-ku Tokyo - Facebook
Watch this amazing compilation of immuno- oncology videos, where we can observe different cell interactions between T cells and other cells! 1) T-Cell activation process⠀ 2) Activated T-Cells …See details»
ティーセルヌーヴォー株式会社の会社情報と資金調達 | NIKKEI …
【NIKKEI COMPASS】ティーセルヌーヴォー株式会社は、「Hybrid CAR-T細胞療法」を用いた、固形がんの治療を研究する三重大学発のベンチャー企業。See details»
News - T Cell Nouveau
Jul 9, 2024 composed with one γchain and one δ chain. Most human peripheral T cells express a TCR composed withα and β glycoprotein chains, and the ratio of γδ T cells is 1-5%. αβ T …See details»
T Cell Nouveau - Overview, News & Similar companies - ZoomInfo
Www.tcellnouveau.com. Revenue $13.8 Million. Industry Business Services General Business Services . Recent News & Media. No recent news or media. Overview ; Who is T Cell …See details»
Announcement on changes in the Executive team - T Cell Nouveau
Announcement on changes in the Executive team.The following nominations of Executive Officers were approved at the 2nd Ordinary General Shareholders Meeting held on February 28, …See details»
News | T Cell Nouveau
Top of page. HOME. NewsSee details»